New Compounds to Fight Breast Cancer
Author Information
Author(s): Adrian Thornton, Rajesh Komati, Hogyoung Kim, Jamiah Myers, Kymmia Petty, Rion Sam, Elijah Johnson-Henderson, Keshunna Reese, Linh Tran, Vaniyambadi Sridhar, Christopher Williams, Jayalakshmi Sridhar
Primary Institution: Xavier University of Louisiana
Hypothesis
Can new p70S6K1 inhibitors effectively inhibit breast cancer cell growth?
Conclusion
The study identified new compounds that inhibit p70S6K1 and reduce the growth of breast cancer cells.
Supporting Evidence
- Three compounds showed sub-micromolar inhibition potency for p70S6K1.
- Compounds inhibited MCF7 cell growth by 40%–60% in the presence of estradiol.
- Substitutions on the phenacetyl group did not enhance inhibition potency.
Takeaway
Scientists created new medicines that can help stop breast cancer cells from growing by blocking a specific protein.
Methodology
The study involved synthesizing new compounds and testing their ability to inhibit p70S6K1 and reduce MCF7 breast cancer cell proliferation.
Limitations
The study primarily focused on in vitro results, which may not fully translate to in vivo effectiveness.
Statistical Information
P-Value
<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website